lifestyle.marketresearchjournals.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
PharmaLogic Holdings Corp
PharmaLogic Announces Successful Supply of First Cohort Dosing for Ratio Therapeutics’ Phase 1/2 Study of a Novel FAP-Targeted Radiopharmaceutical in Late-Stage Aggressive Sarcomas
December 17, 2025